'The light at the end of the tunnel': Moderna says its coronavirus vaccine is 94.5 per cent effective

Global hopes of overcoming the coronavirus pandemic were boosted after a second vaccine was found to be nearly 95 per cent effective in a trial.

A nurse prepares an experimental vaccine for COVID-19 developed by the National Institutes of Health and Moderna Inc. at the United Health Services facility. Source: AAP

Moderna’s experimental vaccine is 94.5 per cent effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second US drugmaker to report results that far exceed expectations.

Together with Pfizer’s vaccine, which is also more than 90 per cent effective, and pending more safety data and regulatory review, the United States could have two vaccines authorized for emergency use in December with as many as 60 million doses of vaccine available this year.

Read the full article in English here.